Arvinas (ARVN) Tax Provisions (2022 - 2026)
Arvinas' (ARVN) quarterly Tax Provisions came in at $100000.0 in Q1 2026, down 50.0% year-on-year from $200000.0 in Q1 2025, and down 50.0% quarter-over-quarter from $200000.0 in Q4 2025.
Arvinas (ARVN) Tax Provisions (2022 - 2026) Analysis & Trends
Arvinas' Tax Provisions history runs 5 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- On a quarterly basis, Tax Provisions fell 50.0% year-over-year to $100000.0 in Q1 2026; TTM through Mar 2026 was $300000.0, a 50.0% decrease from a year earlier, with the FY2025 full-year figure at $300000.0, down 50.0% from the prior year.
- Tax Provisions fell to $100000.0 in Q1 2026 per ARVN's latest filing, from $200000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $10.8 million in Q4 2022 and bottomed at -$400000.0 in Q1 2023.
- The 5-year median for Tax Provisions is $200000.0 (2024), against an average of $1.4 million.
- Across the five-year window, Tax Provisions jumped 166.67% in 2024 and slumped 250.0% in 2025, its largest moves.
- Year by year, Tax Provisions stood at $10.8 million in 2022, then tumbled by 85.19% to $1.6 million in 2023, then slumped by 125.0% to -$400000.0 in 2024, then jumped by 150.0% to $200000.0 in 2025, then sank by 50.0% to $100000.0 in 2026.
- Per Business Quant, the three latest ARVN Tax Provisions figures stand at $100000.0 (Q1 2026), $200000.0 (Q4 2025), and $300000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | -300,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | -400,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 1.60 Mn |
| Jun 30, 2023 | -300,000.00 |
| Mar 31, 2023 | -400,000.00 |
| Dec 31, 2022 | 10.80 Mn |
| Sep 30, 2022 | 2.20 Mn |
| Jun 30, 2022 | 3.40 Mn |
| Mar 31, 2022 | 4.50 Mn |